DIAMOX Sodium Powder for solution for injection

Active ingredients: Acetazolamide

Product name and form

DIAMOX Sodium 500mg Powder for Solution for Injection.

Acetazolamide 500mg Powder for solution for Injection.

Pharmaceutical Form

White to off-white powder for solution for injection.

Qualitative and quantitative composition

Each vial contains Acetazolamide 500mg.

For full list of excipients see section 6.1.

Active Ingredient

Acetazolamide is an enzyme inhibitor which acts specifically on carbonic anhydrase. By inhibiting the reaction catalysed by this enzyme in the renal tubules, acetazolamide increases the excretion of bicarbonate and of cations, chiefly sodium and potassium, and so promotes alkaline diuresis. By inhibiting carbonic anhydrase in the eye acetazolamide decreases intra-ocular pressure and is therefore useful in the treatment of glaucoma.

List of Excipients

Sodium hydroxide (for pH adjustment)

Hydrochloric acid (for pH adjustment)

Pack sizes and marketing

Glass vial with butyl rubber plug and aluminium ring seal.

Pack size 500mg vial.

Marketing authorization holder

Mercury Pharmaceuticals Ltd., Capital House, 85 King William Street, London EC4N 7BL, UK

Marketing authorization dates and numbers

PL 12762/0146

11th February 1988 / 16th February 2004


Austria, Australia, Brazil, Estonia, France, Ireland, Netherlands, New Zealand, Tunisia, United Kingdom